High Purity Survodutide CAS NO.2805997-46-8 Weight Reduction API Powder/

  Product Detail  

1. Features
Survodutide is a dual glucagon (GCGR) and GLP-1 receptor agonist under clinical development for the treatment of obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), and type 2 diabetes. It promotes significant weight loss by reducing appetite, delaying gastric emptying, and increasing energy expenditure, while also improving blood glucose control, liver fat content, and overall metabolic health. Clinical studies have demonstrated promising efficacy in reducing body weight and improving liver-related outcomes.

2. Why Choose Our Peptide Solutions on Echemi?
Reliable Quality Assurance: We specialize in high-end peptide synthesis. Every batch of Survodutide undergoes rigorous internal testing. We provide full documentation, including HPLC and Mass Spectrometry (MS) reports, to ensure maximum purity.
Specialized Logistics & Safe Delivery: Peptides are sensitive. We have a robust global supply chain with "Double Customs Clearance" services. We guarantee 100% safe and discreet delivery to the USA, Europe, UK, Canada, and Australia, ensuring your research is never delayed.
Factory-Direct Competitive Pricing: we offer competitive wholesale pricing for milligram to kilogram scales, providing cost-effective solutions for your industrial and laboratory projects.
Expert Technical Support: Our team has deep expertise in GLP-1 and Glucagon receptor research and is committed to supporting your scientific projects with stable supply and professional service.

3. Important Note & Disclaimer
NOTE: This product is a chemical raw material prepared via chemical synthesis for Laboratory Research and Development (R&D) use only. It is not for human consumption, direct clinical application, or as a finished pharmaceutical product.